3 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke
Stroke AHA/ASA Journal posted on X:
”In the secondary analysis of the ANGEL-REBOOT trial, longer puncture-to-recanalization time was associated with an increased risk of early reocclusion, while general anesthesia and eTICI 2c-3 were associated with a reduced risk of early reocclusion.”
Read the full article here.
ANGEL-REBOOT trial yields important clinical facts!
The findings were published in the research article ”Factors Associated With Early Reocclusion in Recanalized Intracranial Atherosclerotic Occlusion: ANGEL-REBOOT Insights” in Stroke, with following conclusions:
- In patients with intracranial atherosclerotic occlusion (ICAS-O) stroke, early reocclusion after successful mechanical thrombectomy is linked to poor outcomes.
- A post hoc analysis from a multicenter trial identified that longer puncture-to-recanalization time increases the risk of early reocclusion within 24 hours.
- Conversely, general anesthesia and achieving a postprocedural eTICI score of 2c-3 were associated with a lower risk.
These findings offer valuable insights for optimizing procedural strategies to improve outcomes in ICAS-O stroke.
Hemostasis Today, your daily update on the latest scientific advancements on the field of stroke management.
-
Jul 14, 2025, 12:32Anticoagulation in Liver Transplant Candidates: Is Apixaban Safe?
-
Jul 14, 2025, 12:30The Heart: Managing Warfarin-Induced Coagulopathy - New Insights into Handling Prolonged INR Levels
-
Jul 14, 2025, 12:26Investing in the Future of Stroke Innovation: SVIN Pilot Grant Empowers Early-Stage Research in Vascular Neurology
-
Jul 14, 2025, 12:22NEJM Publishes BRIDGE-TNK Trial: IV Tenecteplase Before Thrombectomy in Acute Ischemic Stroke
-
Jul 13, 2025, 15:33ISTH Now Accepting Applications for SSC Leadership Roles
-
Jul 14, 2025, 18:253 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke
-
Jul 14, 2025, 16:12567-Patient Study Confirms LMWH Safety in Pregnancy
-
Jul 13, 2025, 18:182025 ASH ISTH NBDF WFH monitoring report Confirms Strength of 2021 VWD Diagnosis and Management Guidelines
-
Jul 13, 2025, 17:57Preventing VTE in Cancer, Maintaining Low Bleeding Risk: Reduced-Dose Apixaban
-
Jul 13, 2025, 17:172024 NHLBI Workshop Charts Promising Future Directions for ECMO-Induced Coagulopathy
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 6, 2025, 21:00From Untouchable to Editable: How 21st-Century Gene Editing Breakthroughs Clash with Systemic Barriers
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jul 6, 2025, 11:48Japan's Youth Engagement in Hemophilia Care: Where Even the Doctors Get It – HABIT Summit 2025